K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Guanhua Du
also known as Du G, Du Guan-Hua, Du Guanhua
Hunan University of Science and Technology · Academy of Medical Sciences · Target (United States) · Tianjin University of Technology
About this author
Works
1,141
Cited by
29,682
h-index
81
i10
537
ORCID ↗
Top papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang, Dingyu Zhang, Guanhua Du, et al.
·
2020
·
The Lancet
↗ 3,657
OA
Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects
Jianqin Zhang, Chu-Xuan Wu, Li Gao, et al.
·
2019
·
Advances in pharmacology
↗ 415
Skeletal muscle atrophy: From mechanisms to treatments
Lin Yin, Na Li, Weihua Jia, et al.
·
2021
·
Pharmacological Research
↗ 349
The strategies and techniques of drug discovery from natural products
Li Zhang, Junke Song, Linglei Kong, et al.
·
2020
·
Pharmacology & Therapeutics
↗ 279
Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities
Ailin Liu, Haidi Wang, Simon Ming‐Yuen Lee, et al.
·
2008
·
Bioorganic & Medicinal Chemistry
↗ 240
OA
Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro
Xin Mu, Guorong He, Yinxia Cheng, et al.
·
2009
·
Pharmacology Biochemistry and Behavior
↗ 192
Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation
Jie‐Jian Kou, Jun-Zhuo Shi, Yangyang He, et al.
·
2021
·
Acta Pharmacologica Sinica
↗ 190
OA
Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects
Min Li, Aixin Shi, Hongxian Pang, et al.
·
2014
·
Journal of Ethnopharmacology
↗ 182
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
Li Li, Huina Zhang, Hou‐Zao Chen, et al.
·
2011
·
Circulation Research
↗ 181
OA
Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage
Shilun Yang, Haigang Wang, Yinglin Yang, et al.
·
2019
·
Biomedicine & Pharmacotherapy
↗ 164
OA
Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway
Cheng Xiao, Yinglin Yang, Huan Yang, et al.
·
2018
·
International Immunopharmacology
↗ 164
Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
Na He, Shan Su, Zhikang Ye, et al.
·
2020
·
Clinical Infectious Diseases
↗ 163